nach oben

Erschienen in:

12.01.2023 | Koronare Herzerkrankung | Positionspapier von DRG und BDR Zur Zeit gratis

Positionspapier von DRG und BDR zur Computertomographie des Herzens: Klinische Evidenz und Versorgungsqualität beim chronischen Koronarsyndrom

verfasst von: M. C. Langenbach, J. Sandstede, M. M. Sieren, J. Barkhausen, M. Gutberlet, F. Bamberg, L. Lehmkuhl, D. Maintz, C. P. Nähle

Erschienen in: Die Radiologie | Sonderheft 1/2023

Einloggen, um Zugang zu erhalten

Zusammenfassung

Dieses Positionspapier ist eine gemeinsame Stellungnahme der Deutschen Röntgengesellschaft (DRG) und des Berufsverbandes der Deutschen Radiologen (BDR), die den aktuellen Wissenstand über die Computertomographie (CT) des Herzens wiedergibt. Es beruht auf präklinischen und klinischen Studien, welche die klinische Relevanz sowie die technischen Voraussetzungen und Grundlagen der Computertomographie des Herzens untersucht haben.

Moncada R, Salinas M, Churchill R et al (1980) Patency of saphenous aortocoronary-bypass grafts demonstrated by computed tomography. N Engl J Med 303:503–505. https://doi.org/10.1056/NEJM198008283030907CrossRefPubMed

Budoff MJ, Raggi P (2001) Coronary artery disease progression assessed by electron-beam computed tomography. Am J Cardiol 88:46E–50E. https://doi.org/10.1016/s0002-9149(01)01767-2CrossRefPubMed

Achenbach S, Moshage W, Ropers D et al (1998) Value of electron-beam computed tomography for the noninvasive detection of high-grade coronary-artery stenoses and occlusions. N Engl J Med 339:1964–1971. https://doi.org/10.1056/NEJM199812313392702CrossRefPubMed

Mushtaq S, Conte E, Melotti E et al (2019) Coronary CT Angiography in challenging patients: high heart rate and atrial fibrillation. A review. Acad Radiol 26:1544–1549. https://doi.org/10.1016/j.acra.2019.01.022CrossRefPubMed

Anonym (2022) Deutscher Herzbericht 2021. Deutsche Herzstiftung

Mannebach H, Horstkotte D, Arbeitsgruppen Interventionelle Kardiologie et al (2004) 19. Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland Ergebnisse einer gemeinsamen Umfrage der Kommission für Klinische Kardiologie und der Arbeitsgruppen Interventionelle Kardiologie (für die ESC) und Angiologie der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung über das Jahr 2002. Z Kardiol 93:1022–1025. https://doi.org/10.1007/s00392-004-0191-0CrossRefPubMed

Wilkins E, Wilson L, Wickramasinghe K et al (2017) European cardiovascular disease statistics 2017. European Heart Network, Brussels

European Heart Network (2014) Age-standardised death rates from IHD, all ages, by sex, latest available year in the EU

Programm für Nationale VersorgungsLeitlinien (2016) Nationale VersorgungsLeitlinie Chronische KHK

10.

Investigators S‑H, Newby DE, Adamson PD et al (2018) Coronary CT angiography and 5‑year risk of myocardial infarction. N Engl J Med 379:924–933. https://doi.org/10.1056/NEJMoa1805971CrossRef

11.

Hoffmann U, Ferencik M, Udelson JE et al (2017) Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (prospective multicenter imaging study for evaluation of chest pain). Circulation 135:2320–2332. https://doi.org/10.1161/CIRCULATIONAHA.116.024360CrossRefPubMedPubMedCentral

12.

Maron DJ, Hochman JS, Reynolds HR et al (2020) Invasive or conservative strategy for stable coronary disease. N Engl J Med 382:1395–1407. https://doi.org/10.1056/NEJMoa1915922CrossRefPubMedPubMedCentral

13.

Juarez-Orozco LE, Saraste A, Capodanno D et al (2019) Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease. Eur Heart J Cardiovasc Imaging 20:1198–1207. https://doi.org/10.1093/ehjci/jez054CrossRefPubMed

14.

Knuuti J, Wijns W, Saraste A et al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407–477. https://doi.org/10.1093/eurheartj/ehz425CrossRefPubMed

15.

Group DT, Maurovich-Horvat P, Bosserdt M et al (2022) CT or invasive coronary angiography in stable chest pain. N Engl J Med. https://doi.org/10.1056/NEJMoa2200963CrossRef

16.

Haasenritter J, Bösner S, Klug J et al (2011) DEGAM-Leitlinie Nr. 15: Brustschmerz. Z Allg Med. https://doi.org/10.3238/zfa.2011.0182CrossRef

17.

Gutberlet M, Krieghoff C, Gohmann R et al (2019er) Die neuen 2019er-ESC-Leitlinien zur Diagnose und Management des chronischen Koronarsyndroms (CCS): Was ändert sich für die Bildgebung? Radiol up2date 19:391–402. https://doi.org/10.1055/a-0966-5977CrossRef

18.

Reeh J, Therming CB, Heitmann M et al (2019) Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. Eur Heart J 40:1426–1435. https://doi.org/10.1093/eurheartj/ehy806CrossRefPubMed

19.

Möllmann H, Leistner DM, Schulze PC et al (2020) Kommentar zu den Leitlinien (2019) der ESC zum chronischen Koronarsyndrom. Kardiologe 14:482–491. https://doi.org/10.1007/s12181-020-00408-xCrossRef

20.

Saraste A, Barbato E, Capodanno D et al (2019) Imaging in ESC clinical guidelines: chronic coronary syndromes. Eur Heart J Cardiovasc Imaging 20:1187–1197. https://doi.org/10.1093/ehjci/jez219CrossRefPubMed

21.

Foldyna B, Udelson JE, Karady J et al (2019) Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial. Eur Heart J Cardiovasc Imaging 20:574–581. https://doi.org/10.1093/ehjci/jey182CrossRefPubMed

22.

Programm für Nationale VersorgungsLeitlinien (2019) Nationale VersorgungsLeitlinie Chronische KHK

23.

Greenland P, Bonow RO, Brundage BH et al (2007) ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 49:378–402. https://doi.org/10.1016/j.jacc.2006.10.001CrossRefPubMed

24.

Budoff MJ, Shaw LJ, Liu ST et al (2007) Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 49:1860–1870. https://doi.org/10.1016/j.jacc.2006.10.079CrossRefPubMed

25.

Mohlenkamp S, Lehmann N, Moebus S et al (2009) Integration of a new risk marker into cardiovascular prevention, using coronary calcium as an example. Dtsch Med Wochenschr 134:2023–2026. https://doi.org/10.1055/s-0029-1237552CrossRefPubMed

26.

Schmermund A, Mohlenkamp S, Stang A et al (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL study. Risk factors, evaluation of coronary calcium and lifestyle. Am Heart J 144:212–218. https://doi.org/10.1067/mhj.2002.123579CrossRefPubMed

27.

Sarwar A, Shaw LJ, Shapiro MD et al (2009) Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging 2:675–688. https://doi.org/10.1016/j.jcmg.2008.12.031CrossRefPubMed

28.

Bergstrom G, Persson M, Adiels M et al (2021) Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation 144:916–929. https://doi.org/10.1161/CIRCULATIONAHA.121.055340CrossRefPubMedPubMedCentral

29.

Koopman MY, Willemsen RTA, van der Harst P et al (2022) The diagnostic and prognostic value of coronary calcium scoring in stable chest pain patients: a narrative review. Rofo 194:257–265. https://doi.org/10.1055/a-1662-5711CrossRefPubMedPubMedCentral

30.

Gottlieb I, Miller JM, Arbab-Zadeh A et al (2010) The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol 55:627–634. https://doi.org/10.1016/j.jacc.2009.07.072CrossRefPubMedPubMedCentral

31.

Villines TC, Hulten EA, Shaw LJ et al (2011) Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry. J Am Coll Cardiol 58:2533–2540. https://doi.org/10.1016/j.jacc.2011.10.851CrossRefPubMed

32.

Gohmann RF, Lauten P, Seitz P et al (2020) Combined coronary CT-angiography and TAVI-planning: a contrast-neutral routine approach for ruling-out significant coronary artery disease. J Clin Med. https://doi.org/10.3390/jcm9061623CrossRefPubMedPubMedCentral

33.

Seitz P, Krieghoff C, Gottschling S et al (2021) Pre-procedural high-pitch coronary CT angiography assessment of patients undergoing transcatheter aortic valve implantation (TAVI) without patient-specific adjustment: analysis of diagnostic performance. Clin Radiol 76:862 e29–862 e36. https://doi.org/10.1016/j.crad.2021.06.008CrossRefPubMed

34.

Mitchell JD, Fergestrom N, Gage BF et al (2018) Impact of Statins on cardiovascular outcomes following coronary artery calcium scoring. J Am Coll Cardiol 72:3233–3242. https://doi.org/10.1016/j.jacc.2018.09.051CrossRefPubMedPubMedCentral

35.

Yeboah J, Young R, McClelland RL et al (2016) Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol 67:139–147. https://doi.org/10.1016/j.jacc.2015.10.058CrossRefPubMedPubMedCentral

36.

Blaha MJ, Cainzos-Achirica M, Greenland P et al (2016) Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the multi-ethnic study of atherosclerosis (MESA). Circulation 133:849–858. https://doi.org/10.1161/CIRCULATIONAHA.115.018524CrossRefPubMedPubMedCentral

37.

Budoff MJ, Young R, Burke G et al (2018) Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA). Eur Heart J 39:2401–2408. https://doi.org/10.1093/eurheartj/ehy217CrossRefPubMedPubMedCentral

38.

Mahabadi AA, Mohlenkamp S, Lehmann N et al (2017) CAC score improves coronary and CV risk assessment above Statin indication by ESC and AHA/ACC primary prevention guidelines. JACC Cardiovasc Imaging 10:143–153. https://doi.org/10.1016/j.jcmg.2016.03.022CrossRefPubMed

39.

Grundy SM, Stone NJ, Bailey AL et al (2019) 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139:e1046–e1081. https://doi.org/10.1161/CIR.0000000000000624CrossRefPubMed

40.

Arnett DK, Khera A, Blumenthal RS (2019) ACC/AHA guideline on the primary prevention of cardiovascular disease: part 1, lifestyle and behavioral factors. JAMA Cardiol 2019(4):1043–1044. https://doi.org/10.1001/jamacardio.2019.2604CrossRef

41.

DeFilippis AP, Young R, Carrubba CJ et al (2015) An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med 162:266–275. https://doi.org/10.7326/M14-1281CrossRefPubMedPubMedCentral

42.

Cainzos-Achirica M, Quispe R, Dudum R et al (2021) CAC for risk stratification among individuals with hypertriglyceridemia free of clinical atherosclerotic cardiovascular disease. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2021.10.017CrossRefPubMed

43.

Virani SS, Rifai MA (2022) The utility of coronary artery calcium for guiding treatment with preventive pharmacotherapy. JACC Cardiovasc Imaging 15(4):652–654. https://doi.org/10.1016/j.jcmg.2021.11.011CrossRefPubMed

44.

Boden WE, O’Rourke RA, Teo KK et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503–1516. https://doi.org/10.1056/NEJMoa070829CrossRefPubMed

45.

Douglas PS, Hoffmann U, Patel MR et al (2015) Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 372:1291–1300. https://doi.org/10.1056/NEJMoa1415516CrossRefPubMedPubMedCentral

46.

Mancini GBJ, Leipsic J, Budoff MJ et al (2021) CT Angiography followed by invasive angiography in patients with moderate or severe ischemia-insights from the ISCHEMIA trial. JACC Cardiovasc Imaging 14:1384–1393. https://doi.org/10.1016/j.jcmg.2020.11.012CrossRefPubMedPubMedCentral

47.

Bundesgesetzblatt, 2017, Nr. 42, 1966–2067

48.

Adamson PD, Newby DE (2019) The SCOT-HEART trial. What we observed and what we learned. J Cardiovasc Comput Tomogr 13:54–58. https://doi.org/10.1016/j.jcct.2019.01.006CrossRefPubMedPubMedCentral

49.

Ferencik M, Mayrhofer T, Bittner DO et al (2018) Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial. JAMA Cardiol 3:144–152. https://doi.org/10.1001/jamacardio.2017.4973CrossRefPubMedPubMedCentral

50.

Leipsic J, Abbara S, Achenbach S et al (2014) SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 8:342–358. https://doi.org/10.1016/j.jcct.2014.07.003CrossRefPubMed

51.

Gaede L, Möllmann H, Rudolph T et al (2019) Koronarangiografie mit Druckdraht und fraktioneller Flussreserve. Dtsch Arztebl Int 116:205–211. https://doi.org/10.3238/arztebl.2019.0205CrossRefPubMedPubMedCentral

52.

Taron J, Foldyna B, Eslami P et al (2019) Cardiac computed tomography—more than coronary arteries? A clinical update. Rofo 191:817–826. https://doi.org/10.1055/a-0924-5883CrossRefPubMedPubMedCentral

53.

Taylor CA, Fonte TA, Min JK (2013) Computational fluid dynamics applied to cardiac computed tomography for noninvasive quantification of fractional flow reserve: scientific basis. J Am Coll Cardiol 61:2233–2241. https://doi.org/10.1016/j.jacc.2012.11.083CrossRefPubMed

54.

Levine GN, Bates ER, Bittl JA et al (2016) 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for Percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable Ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation 134:e123–155. https://doi.org/10.1161/CIR.0000000000000404CrossRefPubMed

55.

Douglas PS, Pontone G, Hlatky MA et al (2015) Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study. Eur Heart J 36:3359–3367. https://doi.org/10.1093/eurheartj/ehv444CrossRefPubMedPubMedCentral

56.

Gohmann RF, Pawelka K, Seitz P et al (2022) Combined cCTA and TAVR planning for ruling out significant CAD: added value of ML-based CT-FFR. JACC Cardiovasc Imaging 15:476–486. https://doi.org/10.1016/j.jcmg.2021.09.013CrossRefPubMed

57.

Gutberlet M, Krieghoff C, Gohmann R (2020) Is FFRCT a game changer in coronary CT angiography? Herz 45:431–440. https://doi.org/10.1007/s00059-020-04944-wCrossRefPubMed

58.

Hecht HS, Cronin P, Blaha MJ et al (2017) 2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. J Cardiovasc Comput Tomogr 11:74–84. https://doi.org/10.1016/j.jcct.2016.11.003CrossRefPubMed

59.

Mihl C, Maas M, Turek J et al (2017) Contrast media administration in coronary computed tomography angiography—A systematic review. Rofo 189:312–325. https://doi.org/10.1055/s-0042-121609CrossRefPubMed

60.

Soschynski M, Hagar MT, Taron J et al (2022) Update for the performance of CT coronary angiography. Rofo. https://doi.org/10.1055/a-1747-3554CrossRefPubMed

61.

Anonym. Strahlenschutzgesetz vom 27. Juni 2017 (BGBl. I S. 1966), das zuletzt durch Artikel 2 des Gesetzes vom 20. Mai 2021 BGBl. I S. 1194) geändert worden ist

62.

McCollough CH, Bushberg JT, Fletcher JG et al (2015) Answers to common questions about the use and safety of CT scans. Mayo Clin Proc 90:1380–1392. https://doi.org/10.1016/j.mayocp.2015.07.011CrossRefPubMed

63.

FDA (2017) What are the radiation risks from CT?

64.

Shao YH, Tsai K, Kim S et al (2020) Exposure to tomographic scans and cancer risks. JNCI Cancer Spectr. https://doi.org/10.1093/jncics/pkz072CrossRefPubMed

65.

Vijayalakshmi K, Kelly D, Chapple CL et al (2007) Cardiac catheterisation: radiation doses and lifetime risk of malignancy. Heart 93:370–371. https://doi.org/10.1136/hrt.2006.098731CrossRefPubMedPubMedCentral

66.

Kosmala A, Petritsch B, Weng AM et al (2019) Radiation dose of coronary CT angiography with a third-generation dual-source CT in a “real-world” patient population. Eur Radiol 29:4341–4348. https://doi.org/10.1007/s00330-018-5856-6CrossRefPubMed

67.

Tavakol M, Ashraf S, Brener SJ (2012) Risks and complications of coronary angiography: a comprehensive review. Glob J Health Sci 4:65–93. https://doi.org/10.5539/gjhs.v4n1p65CrossRefPubMedPubMedCentral

68.

Jansson K, Fransson SG (1996) Mortality related to coronary angiography. Clin Radiol 51:858–860. https://doi.org/10.1016/s0009-9260(96)80082-1CrossRefPubMed

69.

Aoun J, Hattar L, Dgayli K et al (2019) Update on complications and their management during transradial cardiac catheterization. Expert Rev Cardiovasc Ther 17:741–751. https://doi.org/10.1080/14779072.2019.1675510CrossRefPubMed

70.

BVerfG, 2004

71.

BVerfG, 2010

72.

Coylewright M, Blumenthal RS, Post W (2008) Placing COURAGE in context: review of the recent literature on managing stable coronary artery disease. Mayo Clin Proc 83:799–805. https://doi.org/10.4065/83.7.799CrossRefPubMed

73.

Mortele KJ, Oliva MR, Ondategui S et al (2005) Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol 184:31–34. https://doi.org/10.2214/ajr.184.1.01840031CrossRefPubMed

74.

Wang CL, Cohan RH, Ellis JH et al (2008) Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol 191:409–415. https://doi.org/10.2214/AJR.07.3421CrossRefPubMed

75.

Katayama H, Yamaguchi K, Kozuka T et al (1990) Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175:621–628. https://doi.org/10.1148/radiology.175.3.2343107CrossRefPubMed

76.

Cochran ST (2005) Anaphylactoid reactions to radiocontrast media. Curr Allergy Asthma Rep 5:28–31. https://doi.org/10.1007/s11882-005-0051-7CrossRefPubMed

77.

Newmark JL, Mehra A, Singla AK (2012) Radiocontrast media allergic reactions and interventional pain practice—a review. Pain Phys 15:E665–E675CrossRef

78.

Rosado Ingelmo A, Dona Diaz I, Cabanas Moreno R et al (2016) Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media. J Investig Allergol Clin Immunol 26:144–155. https://doi.org/10.18176/jiaci.0058CrossRefPubMed

79.

Cha MJ, Kang DY, Lee W et al (2019) Hypersensitivity reactions to Iodinated contrast media: a multicenter study of 196 081 patients. Radiology 293:117–124. https://doi.org/10.1148/radiol.2019190485CrossRefPubMed

80.

McDonald RJ, McDonald JS, Bida JP et al (2013) Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 267:106–118. https://doi.org/10.1148/radiol.12121823CrossRefPubMed

81.

McDonald JS, McDonald RJ, Carter RE et al (2014) Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology 271:65–73. https://doi.org/10.1148/radiol.13130775CrossRefPubMed

82.

Davenport MS, Cohan RH, Khalatbari S et al (2014) The challenges in assessing contrast-induced nephropathy: where are we now? AJR Am J Roentgenol 202:784–789. https://doi.org/10.2214/AJR.13.11369CrossRefPubMed

83.

Davenport MS, Khalatbari S, Dillman JR et al (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 267:94–105. https://doi.org/10.1148/radiol.12121394CrossRefPubMedPubMedCentral

84.

Katzberg RW, Newhouse JH (2010) Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology 256:21–28. https://doi.org/10.1148/radiol.10092000CrossRefPubMed

85.

Karlsberg RP, Dohad SY, Sheng R et al (2011) Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium. J Vasc Interv Radiol 22:1159–1165. https://doi.org/10.1016/j.jvir.2011.03.020CrossRefPubMed

86.

Nyman U, Almen T, Jacobsson B et al (2012) Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? Eur Radiol 22:1366–1371. https://doi.org/10.1007/s00330-011-2371-4CrossRefPubMed

87.

van der Molen AJ, Thomsen HS, Morcos SK et al (2004) Effect of iodinated contrast media on thyroid function in adults. Eur Radiol 14:902–907. https://doi.org/10.1007/s00330-004-2238-zCrossRefPubMed

88.

Leung AM, Braverman LE (2012) Iodine-induced thyroid dysfunction. Curr Opin Endocrinol Diabetes Obes 19:414–419. https://doi.org/10.1097/MED.0b013e3283565bb2CrossRefPubMedPubMedCentral

89.

Lee SY, Rhee CM, Leung AM et al (2015) A review: Radiographic iodinated contrast media-induced thyroid dysfunction. J Clin Endocrinol Metab 100:376–383. https://doi.org/10.1210/jc.2014-3292CrossRefPubMed

90.

Rhee CM, Bhan I, Alexander EK et al (2012) Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med 172:153–159. https://doi.org/10.1001/archinternmed.2011.677CrossRefPubMed

91.

Hudzik B, Zubelewicz-Szkodzinska B (2014) Radiocontrast-induced thyroid dysfunction: is it common and what should we do about it? Clin Endocrinol (Oxf) 80:322–327. https://doi.org/10.1111/cen.12376CrossRefPubMed

92.

Dewey M, Hoffmann H, Hamm B (2006) Multislice CT coronary angiography: effect of sublingual nitroglycerine on the diameter of coronary arteries. Rofo 178:600–604. https://doi.org/10.1055/s-2006-926755CrossRefPubMed

93.

Scholtz JE, Baliyan V, Hedgire S et al (2019) Randomized trial comparing transdermal with sublingual nitroglycerin administration for coronary vasodilation in CTA. JACC Cardiovasc Imaging 12:1890–1893. https://doi.org/10.1016/j.jcmg.2019.02.027CrossRefPubMed

94.

Abbara S, Blanke P, Maroules CD et al (2016) SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr 10:435–449. https://doi.org/10.1016/j.jcct.2016.10.002CrossRefPubMed

95.

Bachmann KF, Gansser RE (1988) Nitroglycerin oral spray: evaluation of its coronary artery dilative action by quantitative angiography. Am J Cardiol 61:7–11CrossRef

96.

Takx RAP, Suchá D, Park J et al (2015) Sublingual nitroglycerin administration in coronary computed tomography angiography: A systematic review. Eur Radiol 25:3536–3542. https://doi.org/10.1007/s00330-015-3791-3CrossRefPubMedPubMedCentral

97.

Roberts WT, Wright AR, Timmis JB et al (2009) Safety and efficacy of a rate control protocol for cardiac CT. Br J Radiol 82:267–271. https://doi.org/10.1259/bjr/24574758CrossRefPubMed

98.

Mahabadi AA, Achenbach S, Burgstahler C et al (2010) Safety, efficacy, and indications of beta-adrenergic receptor blockade to reduce heart rate prior to coronary CT angiography. Radiology 257:614–623. https://doi.org/10.1148/radiol.10100140CrossRefPubMed

99.

Raju VM, Gosling OE, Morgan-Hughes G et al (2014) High-dose intravenous metoprolol usage for reducing heart rate at CT coronary angiography: efficacy and safety. Clin Radiol 69:739–744. https://doi.org/10.1016/j.crad.2014.03.003CrossRefPubMed

100.

Al-Hijji MA, Lennon RJ, Gulati R et al (2019) Safety and risk of major complications with diagnostic cardiac catheterization. Circ Cardiovasc Interv 12:e7791. https://doi.org/10.1161/CIRCINTERVENTIONS.119.007791CrossRefPubMed

101.

Anonym (2018) Deutscher Herzbericht 2017. Deutsche Herzstiftung

102.

Anonym (2021) Weiterbildungscurriculum Radiologie

103.

Dos Santos DP, Hempel J‑M, Mildenberger P et al (2019) Structured reporting in clinical routine. In: RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. Thieme, Stuttgart, S 33–39

104.

Morgan TA, Helibrun ME, Kahn CE Jr. (2014) Reporting initiative of the Radiological Society of North America: progress and new directions. Radiology 273:642–645. https://doi.org/10.1148/radiol.14141227CrossRefPubMed

105.

Ghoshhajra BB, Lee AM, Ferencik M et al (2013) Interpreting the interpretations: the use of structured reporting improves referring clinicians’ comprehension of coronary CT angiography reports. J Am Coll Radiol 10:432–438. https://doi.org/10.1016/j.jacr.2012.11.012CrossRefPubMedPubMedCentral

106.

Dunnick NR, Langlotz CP (2008) The radiology report of the future: a summary of the 2007 Intersociety Conference. J Am Coll Radiol 5:626–629. https://doi.org/10.1016/j.jacr.2007.12.015CrossRefPubMed

107.

Radiology ESo (2011) Good practice for radiological reporting. Guidelines from the European Society of Radiology (ESR). Insights Imaging 2:93–96CrossRef

108.

Douglas PS, Hendel RC, Cummings JE et al (2009) ACCF/ACR/AHA/ASE/ASNC/HRS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR 2008 health policy statement on structured reporting in cardiovascular imaging. J Am Coll Cardiol 53:76–90. https://doi.org/10.1016/j.jacc.2008.09.005CrossRefPubMed

109.

Francone M, Budde RPJ, Bremerich J et al (2020) CT and MR imaging prior to transcatheter aortic valve implantation: standardisation of scanning protocols, measurements and reporting—A consensus document by the European Society of Cardiovascular Radiology (ESCR). Eur Radiol 30:2627–2650. https://doi.org/10.1007/s00330-019-06357-8CrossRefPubMed

110.

Bunck AC, Baessler B, Ritter C et al (2020) Structured reporting in cross-sectional imaging of the heart: reporting templates for CMR imaging of cardiomyopathies (myocarditis, dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and siderosis). Rofo 192:27–37. https://doi.org/10.1055/a-0998-4116CrossRefPubMed

111.

Foldyna B, Szilveszter B, Scholtz J‑E et al (2018) CAD-RADS—a new clinical decision support tool for coronary computed tomography angiography. Eur Radiol 28:1365–1372. https://doi.org/10.1007/s00330-017-5105-4CrossRefPubMed

112.

Hecht HS, Blaha MJ, Kazerooni EA et al (2018) CAC-DRS: coronary artery calcium data and reporting system. An expert consensus document of the society of cardiovascular computed tomography (SCCT). J Cardiovasc Comput Tomogr 12:185–191. https://doi.org/10.1016/j.jcct.2018.03.008CrossRefPubMed

113.

Detrano R, Guerci AD, Carr JJ et al (2008) Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358:1336–1345. https://doi.org/10.1056/NEJMoa072100CrossRefPubMed

114.

Osborne-Grinter M, Kwiecinski J, Doris M et al (2021) Association of coronary artery calcium score with qualitatively and quantitatively assessed adverse plaque on coronary CT angiography in the SCOT-HEART trial. Eur Heart J Cardiovasc Imaging. https://doi.org/10.1093/ehjci/jeab135CrossRefPubMedCentral

115.

Cury RC, Abbara S, Achenbach S et al (2016) Coronary artery disease—reporting and data system (CAD-RADS): an expert consensus document of SCCT, ACR and NASCI: endorsed by the ACC. JACC Cardiovasc Imaging 9:1099–1113. https://doi.org/10.1016/j.jcmg.2016.05.005CrossRefPubMed

116.

Macmillan MT, Williams MC (2018) Incidental non-cardiac findings in cardiovascular imaging. Curr Treat Options Cardiovasc Med 20:93–93. https://doi.org/10.1007/s11936-018-0700-5CrossRefPubMedPubMedCentral

117.

Gil BN, Ran K, Tamar G et al (2007) Prevalence of significant noncardiac findings on coronary multidetector computed tomography angiography in asymptomatic patients. J Comput Assist Tomogr 31:1–4. https://doi.org/10.1097/01.rct.0000233125.83184.33CrossRefPubMed

118.

Kim JW, Kang EY, Yong HS et al (2009) Incidental extracardiac findings at cardiac CT angiography: comparison of prevalence and clinical significance between precontrast low-dose whole thoracic scan and postcontrast retrospective ECG-gated cardiac scan. Int J Cardiovasc Imaging 25(Suppl 1):75–81. https://doi.org/10.1007/s10554-008-9417-yCrossRefPubMed

119.

Killeen RP, Dodd JD, Cury RC (2009) Noncardiac findings on cardiac CT part I: Pros and cons. J Cardiovasc Comput Tomogr 3:293–299. https://doi.org/10.1016/j.jcct.2009.05.003CrossRefPubMed

120.

Karius P, Schuetz GM, Schlattmann P et al (2014) Extracardiac findings on coronary CT angiography: a systematic review. J Cardiovasc Comput Tomogr 8(174–182):e171–e176. https://doi.org/10.1016/j.jcct.2014.04.002CrossRef

121.

Onuma Y, Tanabe K, Nakazawa G et al (2006) Noncardiac findings in cardiac imaging with multidetector computed tomography. J Am Coll Cardiol 48:402–406. https://doi.org/10.1016/j.jacc.2006.04.071CrossRefPubMed

122.

Laskowski D, Feger S, Bosserdt M et al (2022) Detection of relevant extracardiac findings on coronary computed tomography angiography vs. invasive coronary angiography. Eur Radiol 32:122–131. https://doi.org/10.1007/s00330-021-07967-xCrossRefPubMed

123.

Lehman SJ, Abbara S, Cury RC et al (2009) Significance of cardiac computed tomography incidental findings in acute chest pain. Am J Med 122:543–549. https://doi.org/10.1016/j.amjmed.2008.10.039CrossRefPubMed

124.

Aglan I, Jodocy D, Hiehs S et al (2010) Clinical relevance and scope of accidental extracoronary findings in coronary computed tomography angiography: a cardiac versus thoracic FOV study. Eur J Radiol 74:166–174. https://doi.org/10.1016/j.ejrad.2009.01.038CrossRefPubMed

125.

Budoff MJ, Fischer H, Gopal A (2006) Incidental findings with cardiac CT evaluation: should we read beyond the heart? Catheter Cardiovasc Interv 68:965–973. https://doi.org/10.1002/ccd.20924CrossRefPubMed

126.

Wichmann JL, Bauer RW, Doss M et al (2013) Diagnostic accuracy of late iodine-enhancement dual-energy computed tomography for the detection of chronic myocardial infarction compared with late gadolinium-enhancement 3‑T magnetic resonance imaging. Invest Radiol 48:851–856. https://doi.org/10.1097/RLI.0b013e31829d91a8CrossRefPubMed

127.

Sala ML, Bizino MB, Amersfoort J et al (2014) Computed tomography evaluation of cardiac structure and function. J Thorac Imaging 29:173–184. https://doi.org/10.1097/RTI.0000000000000080CrossRefPubMed

128.

Panetta D, Gabelloni M, Faggioni L et al (2021) Cardiac computed tomography perfusion: contrast agents, challenges and emerging methodologies from preclinical research to the clinics. Acad Radiol 28:e1–e13. https://doi.org/10.1016/j.acra.2019.12.026CrossRefPubMed

129.

Sieren M, Naehle CP (2021) Current status of cardiovascular imaging in Germany: structured data from the National Certification Programme, ESCR-registry, and survey among radiologists. RöFo. https://doi.org/10.1055/a-1554-9236CrossRefPubMed

130.

Nabavi DG, Ossenbrink M, Busse O (2018) Qualitätsmanagement in der stroke unit. Akt Neurol 45:655–664CrossRef

131.

Breuckmann F, Nabavi DG, Post F et al (2021) Vergleich von chest pain units und stroke units. Herz 46:141–150. https://doi.org/10.1007/s00059-020-04984-2CrossRefPubMed

132.

Foldyna B, Uhlig J, Gohmann R, Lücke C, Mayrhofer T, Lehmkuhl L, Natale L, Vliegenthart R, Lotz J, Salgado R, Francone M, Loewe C, Nikolaou K, Bamberg F, Maintz D, Maurovich-Horvat P, Thiele H, Hoffmann U, Gutberlet M (2022) Quality and safety of coronary computed tomography angiography at academic and non-academic sites: insights from a large European registry (ESCR MR/CT Registry). Eur Radiol. 32(8):5246–5255. https://doi.org/10.1007/s00330-022-08639-0CrossRefPubMed

133.

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (2020) CT- oder MRT-Diagnostik bei Verdacht auf chronische koronare Herzkrankheit: eine Evidenzkartierung

134.

Gemeinsamer Bundessauschuss (2022) Bekanntmachung des Gemeinsamen Bundesausschusses: Computertomographie-Koronarangiographie zur Diagnosestellung bei Patientinnen und Patienten mit Verdacht auf eine chronische koronare Herzkrankheit. Dtsch Arztebl 119(8):A-350/B-286

135.

Beer M, Miller S, Sandstede J et al (2018) Abrechnung Herzdiagnostik mit MRT und CT nach GOÄ. RöFo 190:2

Titel: Positionspapier von DRG und BDR zur Computertomographie des Herzens: Klinische Evidenz und Versorgungsqualität beim chronischen Koronarsyndrom
verfasst von: M. C. Langenbach
J. Sandstede
M. M. Sieren
J. Barkhausen
M. Gutberlet
F. Bamberg
L. Lehmkuhl
D. Maintz
C. P. Nähle
Publikationsdatum: 12.01.2023
Verlag: Springer Medizin
Schlagwörter: Koronare Herzerkrankung
Stabile Angina pectoris
Computertomografie
Computertomografie
Kardio-CT
Erschienen in: Die Radiologie / Ausgabe Sonderheft 1/2023
Print ISSN: 2731-7048
Elektronische ISSN: 2731-7056
DOI: https://doi.org/10.1007/s00117-022-01096-2

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Positionspapier von DRG und BDR zur Computertomographie des Herzens: Klinische Evidenz und Versorgungsqualität beim chronischen Koronarsyndrom

Zusammenfassung

Neu im Fachgebiet Radiologie

Akuter Schwindel: Wann lohnt sich eine MRT?

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Radiologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Radiologie

Akuter Schwindel: Wann lohnt sich eine MRT?

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Radiologie